Retsevmo 40 mg, comprimés pelliculés - 56 Swissmedic Key 70214001 Registration Holder Eli Lilly (Suisse) SA Name Retsevmo 40 mg, comprimés pelliculés Date of registration 21.05.2026 Introduction of Sequence 21.05.2026 ATC-Classification Selpercatinib (L01EX22) Revision date WHO WHO-DDD Valid until 20.05.2031 Index Therapeuticus (BSV) 70000. Show package size 56 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 1419.48 Limitation Yes Limitation text
Deductible 10 % Consumer price 1560.20 Feedback FB Daily cost GTIN 7680702140018 Medication Code Synthetika Pharmacode Disponibility
Composition selpercatinibum 40 mg, cellulosum microcristallinum, carmellosum natricum conexum, hydroxypropylcellulosum, mannitolum, natrii stearylis fumaras, pellicule: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (nigrum), pro compresso obducto corresp. natrium 0.654 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Selpercatinibum 40 mg
BAG: Active Agent Selpercatinibum
Inactive agents Dose additional_information (Nigrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hydroxypropylcellulosum Macrogol 3350 Mannitol Natrii Stearylis Fumaras Poly(Alcohol Vinylicus) pellicule Pro Compresso Obducto Talcum
Source Data was imported : 05.06.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
